And more health news stories you need to start your week.

Jaqueline Corrigan-Curay, who serves as acting head of the FDA’s Center for Drug Evaluation and Research, will depart next ...

But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...

Layoffs at the FDA, USDA and CDC could erode the U.S. food safety system. Experts aren’t so worried about milk or chicken today; they’re concerned about the future.

KalVista Pharmaceuticals has become the latest biotech to face delays to the FDA’s decision-making, as the agency apparently ...

All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...

Curay, who stepped into the role as the agency’s top drug regulator in January, is departing in July, according to an email ...

According to an internal email, the agency may be in for more consolidation in areas including human resources, ...

A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...

When Americans imagine the future, it always has a lot to do with flying cars, robot housekeepers, and just about anything ...

The FDA rejected Stealth BioTherapeutics’ latest bid to market its proposed treatment for an ultra-rare genetic condition, though regulators have suggested a “path” toward accelerated approval.